The Native Antigen Company Appoints Biozol and Shanghai Bioleaf as Distributors

Supplier of reagents for vaccine research, The Native Antigen Company, has revealed its appointment of Biozol and Shanghai Bioleaf as its distributors in Germany, Switzerland, Austria, and China, in a July 11, 2019 press release.

Through the appointment of these two distributors, The Native Antigen Company will gain improved access into the aforementioned territories. Additionally, the distribution agreement will afford researchers in the covered regions to have access to the company’s native and recombinant viral and bacterial antigens, antibodies, and immunoassays.

Andy Lane, commercial director, The Native Antigen Company, said in the press release, “The Native Antigen Company partners with a number of specialist life-sciences distributors around the world, and we are pleased to be expanding this network across Europe and Asia. BIOZOL and Bioleaf are both well-established distributors who have extensive local knowledge and sales infrastructure in these overseas markets which will allow us to deliver our growing range of reagents to researchers working in academia and industry.”

Source: The Native Antigen Company